Q&A with Thelma Bueno, Sr. Clinical Project Manager at genae Americas
Q: Are there any barriers to sites getting approved in a valve trial?
A: To receive approval to market a class II high-risk device in the United States, the manufacturer must demonstrate that the device is reasonably safe and effective; which as we all know, usually requires a prospective, adequately powered clinical trial involving hundreds of patients. So, sponsors need to ensure that their clinical trial is adequately powered.
Discover our other Q&A videos:
• How do you go about ensuring that a site is appropriate for a valve study?
• Are there any specific pieces of information you would include in a site feasibility survey for a valve trial?
• For valve studies, please discuss some specific quirks or intricacies that prevent sites from meeting their enrollment targets?
• What unique aspects of a valve subject population make enrollment/recruitment/retention particularly difficult?
• Are there procedures specific to the conduct of a valve trial that sponsors/principal investigators should be aware of?
• Is there anything in the design of a valve trial that you foresee as a source of difficulty when it comes to executing?
Want to hear more about our services or how we can support your clinical trial? Feel free to contact us with any questions you may have.Contact us